Procter & Gamble Hygiene and Health Care Ltd
PGHH Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management said on revenue, margins and capex.
Top 7 Personal Products companies on management guidance
See the sector's top 10 — free with your mobile number.
What the Q4 FY26 call signalled
0 of 2 strong
The short version
- The company expects balanced and sustained long-term growth, focusing on consumer-centric innovation and category development. - The company aims for sustained double-digit earnings growth over the medium term.
From Procter & Gamble Hygiene and Health Care Ltd's Q4 FY26 earnings-call transcript · updated 24 Jun 2026.
Revenue & Sales Performance
- The company expects balanced and sustained long-term growth, focusing on consumer-centric innovation and category development.
- Feminine hygiene category is projected to grow at a healthy mid to high single-digit rate.
- Healthcare sub-categories are growing at about 2-3%, with some recent volatility due to seasonal factors like monsoons.
- Focus on evolving sub-segments within categories, e.g., night-time feminine hygiene products and period panties, to drive growth.
- Strategy emphasizes continuous investment in superior products, effective marketing, and enhanced go-to-market capabilities to win consumer preference.
- Despite recent flat sales, profit growth and margin expansion reflect productivity savings fueling reinvestment.
2 more points from Procter & Gamble Hygiene and Health Care Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Procter & Gamble Hygiene and Health Care Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- When asked about key areas of investment by the Parent company and future investment outlook, the company refrained from providing any details.
- Similarly, questions on manufacturing footprint expansion and buyback of shares were not answered.
- The company explicitly stated they will withhold sharing unpublished price sensitive or confidential information to protect competitive advantage.
Top-ranked in Personal Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Procter & Gamble Hygiene and Health Care Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Procter & Gamble Hygiene and Health Care Ltd said on order book & pipeline — free account, 30 seconds.
Procter & Gamble Hygiene and Health Care Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹941 Cr, net profit ₹153 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Procter & Gamble Hygiene and Health Care Ltd's management said in earlier quarters
Others in Personal Products this season
- Recode Studios Ltd (Q4 FY26)
The company plans to sustain marketing spends at about 20% of revenue to support growth and brand visibility, implying continued focus on operating profits…
- Anondita Medicare Ltd (Q4 FY26)
Current unexecuted order book stands at approximately INR137 crores, which remains intact from the previous year. Key concall takeaways from Anondita Medicare…
- Cupid Ltd (Q4 FY26)
Q4 FY26 Revenue from operations: ₹119.96 Cr, up 112.39% YoY from ₹56.48 Cr in Q4 FY25 (Page 18). Key concall takeaways from Cupid Ltd's Q4 FY26 earnings call…
- Honasa Consumer Ltd (Q4 FY26)
Increasing contribution from focus categories, which grew 35% year-on-year and now receive over 90% of investments. Key concall takeaways from Honasa Consumer…
Potential multibaggers · Q2 FY27
Potential multibaggers in Personal Products
on management's own guidance
- Strong growth2
- Strong growth1
- Honasa Consumer LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Procter & Gamble Hygiene and Health Care Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Procter & Gamble Hygiene and Health Care Ltd Q1 FY27 results?
- The company expects balanced and sustained long-term growth, focusing on consumer-centric innovation and category development. - The company aims for sustained double-digit earnings growth over the medium term.
What is Procter & Gamble Hygiene and Health Care Ltd share price analysis?
Procter & Gamble Hygiene and Health Care Ltd currently shows a neutral. The stock trades at a P/E of 36.7 with a market cap of ₹31,506. Investors should review the full earnings analysis for detailed insights.
Is Procter & Gamble Hygiene and Health Care Ltd planning capital expenditure?
- When asked about key areas of investment by the Parent company and future investment outlook, the company refrained from providing any details.
Keep Procter & Gamble Hygiene and Health Care Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.